Skip to main content
OpenTrials
Completed

NCT Number: NCT03255863

Determinants of Patients' Uptake of Therapeutic Education Programme

Therapeutic Patient Education (TPE) refers to programs that help patients to manage life with a chronic disease in the best possible way. In spite of the effectiveness of Therapeutic Patient Education, few patients uptake TPE when it is proposed to them. Therefore, our main aim was to identify patients' beliefs that will predict patients' uptake of TPE. According to the Health Belief Model, patient will participate in TPE if they perceive their disease as a serious threat (with possible serious complications), but which can be controlled however, and that TPE is efficient and represents little burden.

Secondary aims are as follows:

1. To test whether the way TPE is presented to patients impact patients' decision to uptake TPE. The way TPE is presented comprises the time between diagnosis and the proposal of TPE, whether patient is a remission or crisis period in the disease, the time between the proposal and the next TPE session, and what is said by healthcare professionals to present TPE. 2. To test whether healthcare professionals' empathy impact patients' decision to participate in TPE 3. To test whether patients' intention to participate in TPE will predict their actual participation.

The ultimate goal of the study is to identify patients whose beliefs will not favor participation in TPE in order to accompany those patients more carefully. Best practices will be proposed according the results.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Claude Huriez, CHU

Lille, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients to whom TPE was proposed in diabetes, hemophilia, obesity, cardiac failure, chronic inflammatory bowel disease, parkinson, rare diseases, epilepsy, peripheral arterial diseases
  • Belong to a social security scheme
  • Pregnant women to whom TPE for gestational diabetes is proposed

Exclusion criteria

  • Cognitive impairment declared by healthcare professionals
  • Inpatients
  • Patients for whom TPE is coupled with rehabilitation
  • Psychiatric disorders
  • Patients who cannot give informed consent
  • Patients in jail

Treatment and study plan

Questionnaire

Other

Patient Self reported questionnaire filled in.

Primary outcomes

  1. Patient's intention to participated in TPE by a questionnaire based on the Health Belief Model

    Time frame: Baseline (after TPE proposal)

    Patient's participation in TPE : yes or no Participation is defined as the patient's intention to come expressly to the hospital for a first appointment dedicated to therapeutic education.

    The main variables of the HBM will be analyzed: perceived threat of the pathology, perceived benefits and barriers to TPE, perceived patient control of its pathology.

Secondary outcomes

  1. Time limit of first proposition in TPE

    Time frame: Baseline

    Time between date of diagnostic illness and date of first first proposition in TPE

  2. Timeout of first participation in TPE

    Time frame: Baseline

    Time between date of proposition and date of the program begin of TPE

  3. Medical context in which TPE is proposed

    Time frame: Baseline

    Medical context in acute phase versus phase of stabilization of the pathology

  4. Consultation And Relational Empathy (CARE) questionnaire

    Time frame: Baseline

    The patient's perceived empathy of the professional (s) who offered the TPE will be assessed by the CARE questionnaire

  5. Visual analog scale for intention to participated

    Time frame: Baseline

    Visual analog scale ranging from 0 "not at all intending to participate" to 100 "very strong intention to participate Measurement of the patient's intention to participate in the proposed TPE program

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Collaborators

  • Ministry of Health, France

Registry information

Acronym: UTEP

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Aug 21, 2017
Registry last updated
Oct 17, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.